Medtronic to announce financial results for its second quarter of fiscal year 2023
Medtronic plc (NYSE:MDT) will report its financial results for Q2 FY2023 on November 22, 2022, with a news release at 5:45 a.m. CST. The report will provide summary financial information for the quarter ending October 28, 2022. A video webcast discussing the results will be held at 7:00 a.m. CST on the same day. Future earnings announcements are scheduled for February 21, 2023, and May 25, 2023. The company emphasizes its commitment to innovative healthcare solutions, addressing various health conditions globally.
- Upcoming earnings report expected to provide insights into financial performance.
- Continued commitment to innovation in healthcare technology.
- None.
DUBLIN, Nov. 15, 2022 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its second quarter of fiscal year 2023 on Tuesday, November 22, 2022. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's second quarter of fiscal year 2023, which ended on Friday, October 28, 2022.
Medtronic will host a video webcast at 7:00 a.m. CST on Tuesday, November 22, 2022, to discuss results for its second quarter of fiscal year 2023. The webcast can be accessed at https://investorrelations.medtronic.com.
Within 24 hours of the broadcast, a replay and transcript of the prepared remarks will be available by clicking on the Investor Events link at https://investorrelations.medtronic.com.
Looking ahead, Medtronic plans to report its fiscal year 2023 third and fourth quarter results on Tuesday, February 21, 2023, and Thursday, May 25, 2023, respectively. For these events, confirmation and additional details will be provided closer to the specific event.
About Medtronic
Bold thinking. Bolder actions. We are Medtronic. Medtronic plc, headquartered in Dublin, Ireland, is the leading global healthcare technology company that boldly attacks the most challenging health problems facing humanity by searching out and finding solutions. Our Mission — to alleviate pain, restore health, and extend life — unites a global team of 95,000+ passionate people across 150 countries. Our technologies and therapies treat 70 health conditions and include cardiac devices, surgical robotics, insulin pumps, surgical tools, patient monitoring systems, and more. Powered by our diverse knowledge, insatiable curiosity, and desire to help all those who need it, we deliver innovative technologies that transform the lives of two people every second, every hour, every day. Expect more from us as we empower insight-driven care, experiences that put people first, and better outcomes for our world. In everything we do, we are engineering the extraordinary. For more information on Medtronic (NYSE:MDT), visit www.Medtronic.com and follow @Medtronic on Twitter and LinkedIn.
Any forward-looking statements are subject to risks and uncertainties such as those described in Medtronic's periodic reports on file with the Securities and Exchange Commission. Actual results may differ materially from anticipated results.
Contacts: | |
Erika Winkels | Ryan Weispfenning |
Public Relations | Investor Relations |
+1-763-526-8478 | +1-763-505-4626 |
View original content to download multimedia:https://www.prnewswire.com/news-releases/medtronic-to-announce-financial-results-for-its-second-quarter-of-fiscal-year-2023-301674371.html
SOURCE Medtronic plc
FAQ
When will Medtronic report its Q2 FY2023 financial results?
What time will the Medtronic financial results be announced?
When is the webcast discussing Medtronic's Q2 FY2023 results?
What are the upcoming earnings report dates for Medtronic in 2023?
